Antibiotic Prophylaxis for Grade 3 Open Fractures: A Retrospective Comparison of Ceftriaxone Plus Vancomycin Versus Cefazolin Plus Gentamicin

Surg Infect (Larchmt). 2024 Feb;25(1):39-45. doi: 10.1089/sur.2023.137. Epub 2023 Dec 11.

Abstract

Background: Because of the established path of bacterial entry and contamination-associated mechanisms, grade 3 open orthopedic fractures represent a substantial infection risk. The Eastern Association for the Surgery of Trauma (EAST) guidelines recommended covering Staphylococcus aureus and adding aminoglycoside gram-negative coverage. Local institutional guidelines rely on ceftriaxone for gram negative coverage and add methicillin-resistant Staphylococcus aureus coverage with vancomycin. Patients and Methods: The electronic health records of adults admitted for a grade 3 open fracture between January 1, 2016, and October 31, 2021, were retrospectively reviewed. Patients who received cefazolin and gentamicin (CZ+GM) or ceftriaxone and vancomycin (CRO+VA) as prophylaxis were included. We recorded the rate of a composite treatment failure outcome of receipt of antibiotic agents, infection-related hospitalization, or subsequent debridement for injury-site skin and soft tissue infection or osteomyelitis. The presence of acute kidney injury (AKI) was also evaluated. Results: There were 65 patients included in the CZ+GM group and 53 patients in the CRO+VA group. Patients in the CZ+GM group were younger (mean 42.6 compared with 50.6 years; p = 0.02). Otherwise, there were no significant differences between groups' demographics, mechanism and site of injury, timeline of care, or surgical interventions. More patients in the CZ+GM arm met the composite treatment failure outcome, but it was not statistically significant (45% vs. 32%; p = 0.2). There were similar rates of treatment failure at 30 days (21% vs. 26%; p = 0.5) and for only osteomyelitis (8% vs. 9%; p = 1). Conclusions: The trend in numerically lower treatment failure rates in the CRO+VA group across outcomes provides sufficient evidence to continue the current local recommendations. Given our sample size, type 2 error may have occurred, and studies with greater power should analyze this question.

Keywords: Gustilo-Anderson; antibiotic prophylaxis; open fracture; orthopedic trauma.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis / adverse effects
  • Cefazolin / therapeutic use
  • Ceftriaxone / therapeutic use
  • Fractures, Open* / complications
  • Fractures, Open* / drug therapy
  • Fractures, Open* / surgery
  • Gentamicins / therapeutic use
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Osteomyelitis* / drug therapy
  • Osteomyelitis* / etiology
  • Osteomyelitis* / prevention & control
  • Retrospective Studies
  • Surgical Wound Infection / prevention & control
  • Vancomycin / therapeutic use

Substances

  • Cefazolin
  • Vancomycin
  • Ceftriaxone
  • Gentamicins
  • Anti-Bacterial Agents